Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorderJournal of Psychopharmacology · 2026-07-16Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-14Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2026-03-01Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.CNS drugs · 2026-03-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-18XÂY DỰNG PHƯƠNG PHÁP ĐỊNH LƯỢNG PSILOCIN VÀ PSILOCYBIN TRONG HUYẾT TƯƠNG NGƯỜI BẰNG LC-MS/MSTNU Journal of Science and Technology · 2026-01-13Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".Global advances in integrative medicine and health · 2026-01-01Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics.Journal of psychopharmacology (Oxford, England) · 2026-01-01Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.Journal of clinical psychopharmacology · 2026-01-01Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder AnalysisResearch Square · 2025-08-19670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?The International Journal of Neuropsychopharmacology · 2025-08-01Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogsJournal of Pharmacological and Toxicological Methods · 2025-05-01Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTSThe international journal of neuropsychopharmacology · 2025-02-01Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.The American journal of psychiatry · 2025-01-01"" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.Integrative cancer therapies · 2025-01-01Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.Palliative medicine reports · 2025-01-01Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.Journal of clinical psychopharmacology · 2025-01-01The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.Journal of psychiatric research · 2024-12-01Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2024-12-01Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.British journal of pharmacology · 2024-10-01Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-06-10Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice.Journal of psychopharmacology (Oxford, England) · 2024-05-01Effect of a single psilocybin treatment on Fos protein expression in male rat brain.Neuroscience · 2024-02-16Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatmentNeuroscience Applied · 2024-01-01Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousnessNeuroscience Applied · 2024-01-01Must Psilocybin Always "Assist Psychotherapy"?The American journal of psychiatry · 2024-01-01Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.The American journal of psychiatry · 2024-01-01Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity.Chinese medical journal · 2023-12-20CHIẾT XUẤT PSILOCIN TỪ NẤM THỨC THẦN LÀM NGUYÊN LIỆU THIẾT LẬP CHUẨNTạp chí Y học Quân sự · 2023-12-11Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-23The psychedelic experience and treatment-resistant depressionWorld Psychiatry · 2023-09-15Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-09-01Psilocybin history, action and reaction: A narrative clinical review.Journal of psychopharmacology (Oxford, England) · 2023-09-01The molecular basis of the antidepressant action of the magic mushroom extract, psilocinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023-07-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2023-01-01Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trialNeuroscience Applied · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Magic mushroom extracts in lipid membranes.Biochimica et biophysica acta. Biomembranes · 2022-09-01Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory miceTranslational Psychiatry · 2022-02-23Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.Journal of psychoactive drugs · 2022-01-01Psychedelics and Mindfulness: A Systematic Review and Meta-AnalysisPsyArXiv · 2021-10-11Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signalingThe FASEB Journal · 2021-05-01Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in pharmacology · 2021-01-01Psilocybin: Psychotherapy or drug?Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin Mushrooms of the World: an identification guide. Paul Stamets.Edinburgh Journal of Botany · 2010-04-26Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-19Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-12-01Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of cognitive neuroscience · 2005-10-01Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2005-06-01The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31